+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Plasma Protein Therapeutics Market (2021 Edition) - Analysis By Product (Ig, Albumin, Factor VIII, Others), Application (Hemophilia, PID, ITP, Others), Application, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2021-2026)

  • PDF Icon

    Report

  • 190 Pages
  • October 2021
  • Region: Global
  • Azoth Analytics
  • ID: 5465008

The Global Plasma Protein Therapeutics Market is estimated at USD 25.4 billion in the year 2020. New plasma-derived therapies is the primary driving factor for the global plasma protein therapeutics market.





Increasing introduction of new plasma-derived therapies with increasing use of Plasma Protein Therapeutics in pharmaceuticals, which are effectively used to treat various diseases like hemostasis and growing awareness on the utilization of various components in the laboratories that are highly effective and promote a modernized way of treatment procedures significantly influences the demand of the global Plasma Protein Therapeutics market.



The plasma protein therapeutics market is also driven by rising incidences of genetic disorder diseases worldwide. Moreover, the trends towards detecting the diseases at an early stage by diagnosing as early as possible is enhancing the growth of the market. From the past two decades, the demand for targeted therapies is growing tremendously, which is solely to level up the growth rate of the market. These factors are additionally fuelling the growth of the overall plasma protein market globally.



Furthermore, the market is experiencing a surge in the demand of advanced therapeutic remedies being developed from the plasma protein because of its effective advantages, thereby driving the growth of the market. Furthermore, the government aids toward the advancing healthcare industry and the favorable reimbursement policies by the health policy investment companies also facilitating the growth of the market.



Scope of the Report:

  • The report presents the analysis of plasma protein market for the historical period 2016-2020 and forecast period of 2021-2026.
  • The report analyses the plasma protein Market by value (USD Million).
  • The report analyses the plasma protein Market by Product (Immunoglobulin, Albumin, Factor VIII, Others).
  • The report analyses the plasma protein Market Application(Hemophilia, PID, ITP, Others).
  • The Global plasma protein Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA) By Country (United States, Canada, Germany, U.K, France, Spain, China, Japan, Australia and South Korea).
  • The key insights of the report have been presented through the frameworks of the attractiveness of the market has been presented by region, by Product and by Application
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include CSL Behring, Baxter International Inc., Takeda Pharmaceutical Company Limited, Biotest AG, Bayer Group, Grifols, S.A., Pfizer, OCTA Pharma, Kedrion bio Pharma, ADMA biologics, Inc.

Key Target Audience:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Consulting and Advisory Firms
  • Government and Policy Makers
  • Regulatory Authorities
Frequently Asked Questions about the Global Plasma Protein Therapeutic Market

What is the estimated value of the Global Plasma Protein Therapeutic Market?

The Global Plasma Protein Therapeutic Market was estimated to be valued at $26.89 Billion in 2021.

What is the growth rate of the Global Plasma Protein Therapeutic Market?

The growth rate of the Global Plasma Protein Therapeutic Market is 7.1%, with an estimated value of $37.9 Billion by 2026.

What is the forecasted size of the Global Plasma Protein Therapeutic Market?

The Global Plasma Protein Therapeutic Market is estimated to be worth $37.9 Billion by 2026.

Table of Contents

1.Report Scope and Methodology
1. Report scope & Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations3. Plasma Protein Market: Product Outlook
4. Global Plasma Protein Market: Sizing and Forecast
4.1 Global Plasma Protein Market Size, By Value, Year 2016-2026
5. Global Plasma Protein Market Segmentation - By Product, By Application
5.1 Competitive Scenario of Global Plasma Protein Market: By Product
5.1.1 Immunoglobulin - Market Size and Forecast (2016-2026)
5.1.2 Albumin- Market Size and Forecast (2016-2026)
5.1.3 Factor VIII - Market Size and Forecast (2016-2026)
5.1.4 Others - Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Plasma Protein Market: By Application
5.2.1 Hemophilia - Market Size and Forecast (2016-2026)
5.2.2 PID (Primary Immunodeficiency Disorder) - Market Size and Forecast (2016-2026)
5.2.3 ITP (Idiopathic Thrombocytopenic Purpura)- Market Size and Forecast (2016-2026)
5.2.4 Others - Market Size and Forecast (2016-2026)
6. Global Plasma Protein Market: Regional Analysis
6.1 Competitive Scenario of Global Plasma Protein Market : By Region
7. North America Plasma Protein Market : An Analysis (2016-2026)
7.1 North America Plasma Protein Market : Size and Forecast (2016-2026), By Value
7.2 North America Plasma Protein Market - Prominent Companies
7.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)
7.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)
7.5 North America Plasma Protein Market: Country Analysis
7.6 Market Opportunity Chart of North America Plasma Protein Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Plasma Protein Market: By Country
7.8 United States Plasma Protein Market: Size and Forecast (2016-2026), By Value
7.9 United States Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
7.10 Canada Plasma Protein Market: Size and Forecast (2016-2026), By Value
7.11 Canada Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
8. Europe Plasma Protein Market: An Analysis (2016-2026)
8.1 Europe Plasma Protein Market : Size and Forecast (2016-2026), By Value
8.2 Europe Plasma Protein Market - Prominent Companies
8.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)
8.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)
8.5 Europe Plasma Protein Market: Country Analysis
8.6 Market Opportunity Chart of Europe Plasma Protein Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Plasma Protein Market: By Country
8.8 Germany Plasma Protein Market: Size and Forecast (2016-2026), By Value
8.9 Germany Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
8.10 United Kingdom Plasma Protein Market: Size and Forecast (2016-2026), By Value
8.11 United Kingdom Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
8.12 France Plasma Protein Market: Size and Forecast (2016-2026), By Value
8.13 France Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
8.14 Spain Plasma Protein Market: Size and Forecast (2016-2026), By Value
8.15 Spain Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
9. Asia Pacific Plasma Protein Market : An Analysis (2016-2026)
9.1 Asia Pacific Plasma Protein Market : Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Plasma Protein Market - Prominent Companies
9.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)
9.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)
9.5 Asia Pacific Plasma Protein Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Plasma Protein Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Plasma Protein Market: By Country
9.8 China Plasma Protein Market: Size and Forecast (2016-2026), By Value
9.9 China Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
9.10 Japan Plasma Protein Market: Size and Forecast (2016-2026), By Value
9.11 Japan Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
9.12 Australia Plasma Protein Market: Size and Forecast (2016-2026), By Value
9.13 Australia Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
9.14 South Korea Plasma Protein Market: Size and Forecast (2016-2026), By Value
9.15 South Korea Plasma Protein Market Segmentation - By Product, By Application (2016-2026)
10. Global Plasma Protein Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Plasma Protein Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Plasma Protein Market - By Application, 2026
11.3 Market Attractiveness Chart of Global Plasma Protein Market - By Region, 2026
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Plasma Protein Companies
12.3 Market Share Analysis
13. Company Analysis
13.1 CSL Behring
13.2 Baxter International Inc.
13.3 Takeda Pharmaceutical Company Limited
13.4 Biotest AG
13.5 Bayer Group
13.6 Grifols, S.A.
13.7 Pfizer
13.8 OCTA Pharma
13.9 Kedrion bio Pharma
13.10 ADMA biologics, Inc.
List of Figures
  • Global Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • Global Demand growth for immunoglobulin in select developed countries in 2018
  • Global GDP per Capita Growth (annual %), 2015-2019
  • World Population 65 Years & Above (% of Total), 2015-2019
  • Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %
  • Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Global Plasma Protein Market - By Product Market Share, 2020 & 2026
  • Global Plasma Protein Market - By Immunoglobulin, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By Albumin, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By Factor VIII, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By Others, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By Application Market Share, 2020 & 2026
  • Global Plasma Protein Market - By Hemophilia, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By PID, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By ITP, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By Others, By Value (USD Million), 2016-2026
  • Global Plasma Protein Market - By Region Market Share, 2020 & 2026
  • North America Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
  • North America Current Healthcare Expenditure per Capita, 2015-2018 (In Numbers)
  • North America Prevalence of Total Cancer, 2015-2019 (In Millions)
  • North America Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • North America Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Market Opportunity Chart of North America Plasma Protein Market - By Country, By Value (Year 2016-2026)
  • North America Plasma Protein Market - By Country Market Share, 2020 & 2026
  • United States Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • United State Monthly Industry Aggregation Immunoglobulin (IG) Jan-June 2021 (In KG)
  • United State Monthly Industry Aggregation Plasma Derived Factor VIII Jan-June 2021 (In KG)
  • United State Monthly Industry Aggregation Albumin 25% Concentration Jan-June 2021 (In KG)
  • United State Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • United State Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Canada Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Canada Urban population, 2015-2019 (In %)
  • Canada Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Canada Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Europe Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • Europe Monthly Distribution - IVIG, Jan-May 2021 (In KG)
  • Europe Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021
  • Europe Monthly Distribution Albumin 20 - 25% SUPPLY Jan-May 2021 (In KG)
  • Europe Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Europe Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Market Opportunity Chart of Europe Plasma Protein Market - By Country, By Value (Year 2016-2026)
  • Europe Plasma Protein Market - By Country Market Share, 2020 & 2026
  • Germany Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • Germany Monthly Distribution - IVIG, Jan-May 2021 (In KG)
  • Germany Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021
  • Germany Monthly Distribution Albumin 20 - 25% SUPPLY Jan-May 2021 (In KG)
  • Germany Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Germany Plasma Protein Market - By Application, By Value (USD Million), 2016-2026United Kingdom Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • United Kingdom Monthly Distribution - IVIG, Jan-May 2021 (In KG)
  • United Kingdom Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021
  • United Kingdom Monthly Distribution Albumin 20 - 25% SUPPLY Jan-May 2021 (In KG)
  • United Kingdom Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • United Kingdom Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • France Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Figure 61: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • France Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • France Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Spain Plasma Protein market Size, By Value, 2016-2026 (USD Million)
  • Spain Monthly Distribution - IVIG, Jan-May 2021 (In KG)
  • Spain Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021 (In KG)
  • Spain Monthly Distribution Albumin 20 - 25% SUPPLY (Kgs) Jan-May 2021 (In KG)
  • Spain Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Spain Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Asia Pacific Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Asia Pacific Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Asia Pacific Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Figure 76: Market Opportunity Chart of APAC Plasma Protein Market - By Country, By Value (Year-2026)
  • APAC Plasma Protein Market - By Country Market Share, 2020 & 2026
  • China Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • China Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • China Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Japan Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
  • Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Japan Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Japan Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Australia Plasma Protein market Size, By Value, 2016-2026 (USD Million)
  • Australia Current Healthcare Expenditure Per Capita, 2015-2018 (Current USD)
  • Australia Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
  • Australia Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • Australia Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • Australia Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • South Korea Plasma Protein Market Size, By Value, 2016-2026 (USD Million)
  • South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
  • South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
  • South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
  • South Korea Plasma Protein Market - By Product, By Value (USD Million), 2016-2026
  • South Korea Plasma Protein Market - By Application, By Value (USD Million), 2016-2026
  • Market Attractiveness Chart of Global Plasma Protein Market - By Product (Year-2016-2026)
  • Market Attractiveness Chart of Global Plasma Protein Market - By Application (Year 2016-2026
  • Market Attractiveness Chart of Global Plasma Protein Market - By Region (Year 2016-2026)
  • Global Plasma Protein company market share (%), 2020
  • CSL Behring Sales Revenues, 2016-2019 (USD Million)
  • CSL Behring Net Profit, 2016-2019 (USD Million)
  • CSL Behring Sales Revenue Split, By Business Segment (%), FY2019
  • CSL Behring Sales Revenue Split, By Geography Segment (%), FY2019
  • Baxter International Inc. Sales Revenues, 2016-2020 (USD Million)
  • Baxter International Inc. Gross Profit, 2016-2020 (USD Million)
  • Baxter International Inc. Sales Revenue Split, By Business Segment (%), FY2020
  • Baxter International Inc. Sales Revenue Split, By Geography Segment (%), FY2020
  • Takeda Pharmaceutical Company Limited Sales Revenues, 2016-2020 (USD Million)
  • Takeda Pharmaceutical Company Limited Net Income, 2016-2020 (USD Million)
  • Takeda Pharmaceutical Company Limited Sales Revenue Split, By Business Segment (%), FY2020
  • Takeda Pharmaceutical Company Limited Sales Revenue Split, By Geography Segment (%), FY2020
  • Biotest AG Sales Revenues, 2016-2020 (USD Million)
  • Biotest AG Gross Profit, 2016-2020 (USD Million)
  • Biotest AG Sales Revenue Split, By Business Segment (%), FY2020
  • Biotest AG Sales Revenue Split, By Geography Segment (%), FY2020
  • Bayer Group Sales Revenues, 2016-2020 (USD Million)
  • Bayer Group Net Profit, 2016-2020 (USD Million)
  • Bayer Group, By Business Segment (%), FY2020
  • Bayer Group, By Geographical Segment (%), FY2020
  • Grifols, S.A. Sales Revenues, 2016-2020 (USD Million): Grifols, S.A. Sales Revenue Split, By Business Segment (%), FY2020
  • Grifols, S.A. Sales Revenue Split, By Business Segment (%), FY2020
  • Pfizer Annual Sales Revenue (USD Million), 2016-2020
  • Pfizer Annual Net Income/Loss (USD Million), 2016-2020
  • Pfizer sales Revenue, By Geographical Segment (%), FY2020
  • Octapharma USA Inc. Sales Revenues, 2016-2020 (USD Million)
  • Octapharma USA Inc. Net Profit, 2016-2020 (USD Million)
  • Kedrion Biopharma Sales Revenues, 2016-2020 (USD Million)
  • Kedrion Biopharma Sales Revenue Split, By Geography Segment (%), FY2020
  • ADMA Biologics, Inc. Sales Revenues, 2016-2020 (USD Million)
  • ADMA Biologics, Inc. Sales Revenue Split, By Business Segment (%), FY2020

Methodology

Loading
LOADING...